C.3.3.7 Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Up22

Table of Contents

Executive summary

1. Introduction (background)

2. Scope

3. Legal basis

4. Determination of health based exposure limits

5. Specific considerations

6. Reporting of the PDE determination strategy

7. Implementation

8. Definitions

References:

Annex